A detailed history of Allworth Financial LP transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Allworth Financial LP holds 53,734 shares of BIAF stock, worth $15,582. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,734
Holding current value
$15,582
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 07, 2025

BUY
$0.2 - $1.09 $10,746 - $58,570
53,734 New
53,734 $15,000

Others Institutions Holding BIAF

About bioAffinity Technologies, Inc.


  • Ticker BIAF
  • Exchange
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 2,727,580
  • Market Cap $791K
  • Description
  • bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...
More about BIAF
Track This Portfolio

Track Allworth Financial LP Portfolio

Follow Allworth Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Allworth Financial LP with notifications on news.